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Abstract 
Human B cells appropriately activated by a B cell mitogen are rendered susceptible to human 
Interleukin 2 (IL-2) as demonstrated with recombinant human IL-2 (rec. h IL-2). They show 
increased proliferation and drastically enhanced immunoglobulin secretion. Susceptibility to 
IL-2 is accompanied with the expression of the IL-2 receptor (Tac antigen) on B cells. The data 
suggest that IL-2 is one of the lymphokines directly involved in the activation of B 
lymphocytes. 
Results and Discussion 
Interleukin 2 (IL-2) has been considered as a lymphokine which acts 
exclusively on T cells by binding to the IL-2 receptor which is exposed after 
appropriate activation (1,2). It is known as a sialoglycoprotein of molecular 
weight 15,000 (3) with hormone-like activity. IL-2 is required for prolifer-
ation and expansion of T cells in long-term culture in vitro. In general, 
short-term culture supernatants of polyclonally activated lymphocytes have 
been used as IL-2 sources which obviously contain, beside Il-2, a variety of 
other lymphokines difficult to separate biochemically. Even cloned T cell 
lines may produce severallymphokines (4, 5). However, since recombinant 
IL-2 is now available a more precise functional analysis of that molecular 
entity should start. 
Here we demonstrate that human recombinant IL-2 (rec. h IL-2, Sandoz, 
Wien) promotes proliferation (Table 1) and differentiation (Table 3) of 
human B cells extensively deprived of T cells and prestimulated with an 
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appropriate B cell activator. B cell proliferation was determined by 3H_ 
thymidine incorporation whereas differentiation was determined as 
increased immunoglobulin secretion in culture supernatants measured by 
solid-phase ELISA. In order to rule out an effect of rec. h IL-2 on residual 
T cells, this population was removed carefully. This was achieved by 
rosetting human lymphocytes from spleen or peripheral blood by AET-
treated sheep erythrocytes followed by lysis of the remaining T cells with 
two distinct mono clonal (mAb) anti-T cell antibodies (OKT 3, Ortho; 
Lyt 3, NEN) and rabbit complement. In addition, to exclude minimum 
contamination by T cells, cultures with low cell concentrations (2.5 X 104 B 
cells per round-bottom microtiter well) were established for both prolifera-
tion and Ig secretion. Cytofluorometric analyses revealed no contamination 
of T cells considering a detection threshold of 1 % (data not shown). More 
importantly, T cell depletion of the B cell preparation was demonstrated 
functionally in assays for proliferation and Ig secretion using the T cell 
mitogenic mAb OKT 3 (see ref. 6). It is shown that this monoclonal 
antibody added either directly or in the presence of rec. h IL-2 to T cell 
depleted B lymphocyte populations failed to induce proliferative responses 
comparable to those with rec. h IL-2 alone (Table 1). Control experiments 
showed that purified T4 cells are only activated under similar conditions in 
the presence of exogenous accessory cells (Table 2) as reported before (7). 
The fact that the addition of the same amount of exogenous accessory cells 
to the enriched B cell population did neither support an activation by 
Table 1. Proliferation of human B cells promoted by rec. h IL-2 as second signal 
Pre- rec. h IL-2 cpm 
activation (ng/ml) 
(1. Signal) (2. Signal) Exp. 1 Exp. 2 
102 102 
SAC 2908 870 
+ (50) 870 1543 
SAC + (10) 8280 n.d. 
SAC + (50) 12800 6420 
OKT3 140 114 
OKT3 + (50) 920 1384 
Human B cells were prepared as rosette-negative populations from spleen lymphocytes by 
rosetting with AET -treated sheep erythrocytes followed by complement-mediated cytolysis of 
residual T cells by OKT3 and Lyt3 combined with depletion of monocytes by plastic dish 
adherence. 2.5 X 104 B cells were cultured in triplicates in 200 III RPMI 1640 (Gib co) 
supplemented with 10 % FCS. Heat-killed SAC particles (0.001 % v/v) or OKT3 (2.5 ng/ml) 
were used as first signal and rec. h IL-2 (10 or 50 ng/ml ~ 100 and 500 arbitrary units) as 
second signal. The functional activity of rec. h IL-2 was determined by standard titrations 
using the IL-2 dependent T cell line CTLL-2 (kindly provided by Dr. S. Gillis [Seattle, WA, 
USA]). One unit was arbitrarily defined as the amount of rec. h IL-2 (= 100 pg) which 
guarantees half maximal proliferation of 2 x 10' CTLL after 24 h. Mean cpm values are given 
in the Table (3 d culture, 18 h 'H-thymidine incorporation, 1 IlCi per culture). 
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Table 2. Proliferation of the human T4 subpopulation induced by rec. h IL-2 as second signal 
1 X 103 
monocytes added 
per culture 
+ 
+ 
Pre-
acitivation 
(1. Signal) 
OKT3 
OKT3 
OKT3 
rec. h IL-2 
10 ng/ml 
(2. Signal) 
+ 
+ 
+ 
cpm 
38 
128 
256 
973 
8125 
Human T4 (helper/inducer) cells were prepared by AET-rosetting followed by a second 
rosetting-step with OKT4-Protein A coupled sheep erythrocytes. Monocytes were obtained as 
plastic adherent blood lymphocytes. OKT3 and rec. h IL-2 were used according to Table 1. 2.5 
x 104 T4 cells were cultured in triplicates in 200 ftl RPMI 1640 with 10 % FCS. Mean cpm 
values are given (3 d culture, 15 h 3H-thymidine incorporation, 1 ftCi per culture). 
OKT3 nor influence the B cell activation by Staphylococcus A strain 
Cowan I particles (SAC) again indicates the lack of contaminating T cells 
and suggests that B cell activation by SAC is accessory cell independent (F. 
EMMRICH, manuscript in preparation). 
The SAC commonly used as polyclonal pre-activators for the determina-
tion of human B cell growth and B cell differentiation (8, 9) were prepared 
as described (10). As shown in Table 1, SAC by itself stimulates B cells to 
proliferate to a certain extent as described recently (8). The simultaneous 
addition of rec. h IL-2 resulted in a further substantial increase of 3H_ 
Table 3. IgG secretion of human B cells induced by rec. h IL-2 as second signal 
T cells added preactivation rec. h IL-2 IgG 
per culture (1. Signal) (2. Signal) (ng/ml) 
0 
SAC 190 
+ (50) 0 
SAC + (10) 12100 
SAC + (50) 25000 
OKT3 0 
OKT3 + (50) 0 
103 OKT3 + (50) 2.5 
5 x 103 OKT3 + (50) 50 
For B cell preparation see Table 1. T cells were prepared by AET -rosetting from peripheral 
blood lymphocytes. The T cell population contained 60 % T4 cells as indicated by cyto-
fluorometry. 2.5 X 10' B cells were cultured for 12 days in triplicates in 200 ftl RPMI 1640 
supplemented with 10 % FCS. SAC, OKT3 and rec. h IL-2 were used according to Table 1. 
Human IgG was determined in culture supernatants by a solidphase ELISA using dilutions of 
a WHO-calibrated human serum as reference. (0) indicates values below 1 ng/as determined 
from the standard curve. 
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Fig. 1. The human IL-2 receptor (Tac-antigen) is expressed after appropriate preactivation of B 
cells. For B cell preparation see Table 1. Samples of cryopreserved human B cells were cultured 
for two days with 0.001 % SAC (B) or thawed directly before staining (A). Tac expression was 
analyzed cytofluorometrically (Ortho 50-H) using an FITC labelled anti-mouse-Ig F(ab'), 
(Tago) as second antibody. For control, either the second antibody alone (sec. ab) or an 
irrelevant monoclonal antibody (10F59) of the same isotype as anti-Tac (IgG 2a/K) was used. 
10F59 is directed to a human Ig idiotope (13). Anti-Tac and 10F59 were adjusted to same Ig 
concentrations (2 ~g/ml). The threshold of positive versus negative cells was adjusted so that 
6--10 % fluorescence-positive cells were found in the controls. Under these conditions, 28.4 % 
Tac-positive cells were found in presensitized human B cells. 
thymidine incorporation indicating growth factor aCtIvity of IL-2 for 
preactivated B cells. When added alone, the rec. h IL-2 by itself could 
induce low but significant proliferation which is presumably due to low 
numbers of B cells pre-activated either in vivo or by fetal calf serum 
components present in the cultures. 
Although the rec. h IL-2 is prepared from E. coli and contains a minute 
contamination of bacterial lipopolysaccharide (0.27 ng LPS/mg IL-2 as 
determined in the Limulus assay by Sandoz, Wien, it should be noted that 
in the human system LPS does not act as a polyclonal B cell activator (11). 
Moreover, the quantities of LPS used for polyclonal activation of mouse B 
cells differ in some orders of mangitude from possible LPS contaminations 
in the rec. h IL-2 preparation. LPS preparations (kindly provided by Dr. C. 
GALANOS, Freiburg, FRG) showed no direct proliferative effect on human 
B cells nor did they provide an additional signal after appropriate preactiva-
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tion (data not shown). Table 3 demonstrates the pronounced promoting 
effect of rec. h IL-2 for IgG secretion in purified B cells preactivated by 
SAC, whereas SAC alone, as well as rec. h IL-2 alone, failed to do so. 
Again, the addition of small amounts of T cells to the B cell culture did not 
support a comparable IgG secretion (Table 3). 
Studies were undertaken to investigate the putative IL-2 receptor on B 
cells. As shown in Fig. 1, a monoclonal antibody which has been demon-
strated to bind to the human IL-2 receptor on activated T cells (anti-Tac, 
ref. 12) also stained SAC-activated B cells. In addition, the same anti-Tac 
antibody could inhibit the transmission of the signal provided by rec. h IL-
2 (F. EMMRICH, manuscript in preparation). The combined data, therefore, 
argue for the expression of similar IL-2 receptors on both Band T cells 
activated by the appropriate mitogens. 
In conclusion, the data presented show clearly that activated human B 
cells are susceptible for signals provided by rec. h IL-2 and suggest that this 
lymphokine is involved in the differentiation and proliferation of B lym-
phocytes. Similar results have also been obtained with the same IL-2 source 
using antigen or mitogen activated mouse B lymphocytes (H. MOLL et al., 
manuscript in preparation). Thus, recombinant lymphokine probes appear 
to be very useful reagents to re examine well-established views concerning 
lymphokine functions. 
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